PK Study of Oral Rivaroxaban in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- Sponsors Janssen
- 01 Feb 2017 Last checked against ClinicalTrials.gov record.
- 29 Mar 2012 Actual patient number changed from 2 to 50 according to ClinicalTrials.gov.
- 29 Mar 2012 Actual end date (December 2011) added as reported by ClinicalTrials.gov.